A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer

BACKGROUND: Bladder cancer (BC) is a molecular heterogeneous malignant tumor; the treatment strategies for advanced-stage patients were limited. Therefore, it is vital for improving the clinical outcome of BC patients to identify key biomarkers affecting prognosis. Ferroptosis is a newly discovered...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Libo, Li, Chunyan, Qin, Yang, Zhang, Guoying, Zhao, Bin, Wang, Ziyuan, Huang, Youguang, Yang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378228/
https://www.ncbi.nlm.nih.gov/pubmed/34422642
http://dx.doi.org/10.3389/fonc.2021.686044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378228/
https://www.ncbi.nlm.nih.gov/pubmed/34422642
http://dx.doi.org/10.3389/fonc.2021.686044

Ejemplares similares